Recent Price Movement and Market Context
On 8 December 2025, Entero Healthcare Solutions' share price touched Rs.1015, the lowest level recorded in the past year. This movement comes after the stock underperformed its sector by 1.04% during the trading session. Over the last three trading days, the stock has recorded a cumulative return of -2.8%, indicating sustained downward momentum.
The broader market, represented by the Sensex, opened flat but later declined by 242.55 points, or 0.39%, closing at 85,382.29. Despite this, the Sensex remains close to its 52-week high of 86,159.02, trading just 0.91% below that peak. The index is currently positioned above its 50-day moving average, which itself is above the 200-day moving average, signalling a generally bullish trend for the market overall.
In contrast, Entero Healthcare Solutions is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This technical positioning highlights the stock's relative weakness compared to the broader market and its sector peers.
Long-Term and Recent Performance Metrics
Over the past year, Entero Healthcare Solutions has recorded a total return of -30.34%, a stark contrast to the Sensex's positive return of 4.51% during the same period. The stock's 52-week high was Rs.1564.95, indicating a substantial decline from its peak price.
When compared to the BSE500 index, the stock has underperformed not only in the last year but also over the previous three years and the last three months. This extended period of relative underperformance has contributed to the current valuation pressures on the stock.
Strong fundamentals, solid momentum, fair price – This Large Cap from the NBFC sector checks every box for our Top 1%. This should definitely be on your radar!
- - Complete fundamentals package
- - Technical momentum confirmed
- - Reasonable valuation entry
Financial Health and Operational Highlights
Despite the stock's price challenges, Entero Healthcare Solutions demonstrates a strong capacity to manage its debt obligations, with a Debt to EBITDA ratio of 1.33 times. This indicates a relatively low leverage position, which can be favourable for financial stability.
The company has reported consistent positive results over the last seven consecutive quarters. Its quarterly net sales reached a peak of Rs.1,570.95 crore, while quarterly PBDIT (Profit Before Depreciation, Interest and Taxes) hit Rs.62.06 crore, the highest recorded in recent periods. The operating profit margin relative to net sales also reached a quarterly high of 3.95%, reflecting operational efficiency in recent quarters.
Valuation and Profitability Metrics
Entero Healthcare Solutions holds a Return on Capital Employed (ROCE) of 8.6%, which is considered attractive within its sector. The company's enterprise value to capital employed ratio stands at 2.3, suggesting a valuation discount relative to its peers' historical averages.
Interestingly, while the stock price has declined by over 30% in the past year, the company's profits have risen by 142% during the same period. This divergence is reflected in a PEG ratio of 0.3, indicating that profit growth has outpaced the stock price movement.
Shareholding and Institutional Interest
Institutional investors hold 24.32% of Entero Healthcare Solutions' shares. Such holdings often indicate a level of confidence in the company's fundamentals, given the resources and analytical capabilities these investors typically possess.
Considering Entero Healthcare Solutions ? Wait! SwitchER has found potentially better options in Retailing and beyond. Compare this small-cap with top-rated alternatives now!
- - Better options discovered
- - Retailing + beyond scope
- - Top-rated alternatives ready
Sector and Industry Overview
Entero Healthcare Solutions operates within the retailing industry and sector, which has experienced mixed performance in recent months. While the broader market indices such as the Sensex have maintained a generally bullish stance, individual stocks within the retailing sector have faced varying degrees of pressure. Entero Healthcare Solutions' recent price movements reflect these sector-specific dynamics as well as company-specific factors.
The stock's current position below all major moving averages contrasts with the Sensex's position above its 50-day and 200-day moving averages, underscoring the divergence between the company’s share price trajectory and the broader market trend.
Summary of Key Price and Performance Indicators
To summarise, Entero Healthcare Solutions' stock price has declined to Rs.1015, marking a 52-week low. The stock has recorded a negative return of 30.34% over the past year, underperforming the Sensex and BSE500 indices. Despite this, the company has demonstrated strong sales growth, improved profitability, and a solid balance sheet with manageable debt levels.
The stock’s technical indicators show it trading below all significant moving averages, reflecting recent price weakness. Meanwhile, institutional shareholding remains notable at 24.32%, indicating continued interest from larger investors.
Conclusion
Entero Healthcare Solutions’ recent decline to its 52-week low highlights the challenges faced by the stock amid broader market fluctuations and sector pressures. While the share price has moved lower, the company’s financial metrics reveal ongoing growth in sales and profits, alongside a stable debt profile. These factors provide a comprehensive view of the stock’s current standing within the retailing sector.
Limited Time Only! Upgrade now and get 1 Year of Stock of the week worth Rs. 14,999 for FREE. Don't miss out on this exclusive offer. Claim Your Free Year →
